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BACKGROUND: Isolated groups, such as first generation non-Western immigrants, are at risk for suboptimal utilisation of the health care
system resulting in a worse outcome.
METHODS: From 1989 to 2007, all patients with stomach cancer were selected from the Comprehensive Cancer Centre North-East
cancer registry. Associations between country of birth and patient, tumour and treatment characteristics were determined
using w
2 analysis. Relative survival analysis was used to estimate relative excess risk of dying according to country of birth
(non-Western vs Western).
RESULTS: After adjusting for confounding factors (patient, tumour and treatment related), the risk of dying was lower for first
generation non-Western immigrants (relative excess risk 0.55, 95% confidence interval 0.43–0.70) compared with Western patients.
CONCLUSION: Although the better survival of first generation non-Western immigrants with stomach cancer remains unexplained,
it argues against accessibility problems within the Dutch health care system.
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The Dutch health care system, financially based on an obligatory
insurance coverage, is designed to provide essential health care
to all citizens. However, isolated groups might be at risk for
suboptimal care whether in a social, cultural, religious and/or
communicative way (Waller et al, 2009). A group that would fit
these characteristics are first generation immigrants from non-
Western origin because of factors related to the migration process,
such as health status, self perceived needs, health seeking
behaviour, language barriers, or other cultural or religious
differences, which might increase patient delay and influence
outcome of care.
Accessibility of health care is particularly relevant in diseases,
like stomach cancer, in which care and outcome are highly
dependent on early detection; it therefore provides a valuable
opportunity of using survival as an endpoint, as delayed diagnosis
and under-treatment would influence survival. For this purpose,
we analysed data on survival of stomach cancer in the North East
Netherlands for first generation non-Western immigrants com-
pared with Western immigrants and native patients.
MATERIALS AND METHODS
All cases of stomach cancer (ICD-10 code C16) diagnosed between
1 January 1989 and 31 December 2007 (n¼9239) were selected
from the population-based cancer registry of the Comprehensive
Cancer Centre North East (CCCNE: 3.2 million inhabitants). First
notifications are obtained from the nation wide network and
registry of histo- and cytopathology in Netherlands (PALGA) and
the national registry of hospital discharge, radiotherapy institu-
tions and haematology departments. Information on patient
characteristics and tumour characteristics such as sub-site
(International Classification of Diseases for Oncology (ICD-O-3)
(Wittekind et al, 2005), histology, stage (tumour lymph node
metastasis (TNM) classification (Sobin and Wittekind, 2002)), and
grade, are obtained routinely from the medical records B9 months
after diagnosis (Siesling et al, 2003). The quality of the data is high,
completeness being estimated to be at least 95% (Schouten et al,
1993). Follow-up of vital status of all patients was initially obtained
from municipal registries and from 1995 from the nationwide
municipal population registries network and was calculated as the
time from diagnosis to death or to 1 January 2008.
The cancer registry obtains country of birth from the patient
files in the hospitals. When a hospital does not collect this
information, the country of birth is coded as ‘unknown’. An
unknown country of birth therefore depends on the hospital in
which the patient is diagnosed and not on the patient. Of the 9239
patients, 1863 had an unknown country of birth and were excluded
from the analyses. Of the remaining 7376 patients, 7259 were born
in Europe (excluding Turkey), North America, Australia and New
Zealand, and were coded as Western immigrants or native patient;
those born in other countries were coded as non-Western
immigrants (Table 1, n¼117).
Statistical analysis
Associations between country of birth, age at diagnosis, stage of
disease, localisation of the tumour, histological grade of the
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2 analysis and calcu-
lating 95% confidence intervals (CI). Localisation was divided
into proximal (C16.0 and C16.1), distal (C16.2, C16.3, C16.4, C16.5
and C16.6), overlapping lesions (C16.8) and not otherwise
specified (C16.9).
As information on cause of death is not available in the cancer
registry, relative survival was used as an estimation of disease-
specific survival. This adjusts for survival in the general population
with the same structure for age and gender, and is calculated as
the ratio of the observed rates in cancer patients to the expected
rates in the general population (Hakulinen and Abeywickrama,
1985). Multivariable 5-year survival analyses were conducted to
discriminate independent risk factors for death, expressed in
relative excess risk of dying (RER). Year of diagnosis was divided
into categories and put into the multivariable model to see if there
were changes in survival over time. Patients with unknown stage of
disease were excluded from the survival analyses (n¼1415).
Statistical analysis was performed with Stata version 10 (StataCorp
LP, College Station, TX, USA).
RESULTS
The majority of the 7376 patients were male (66%). The mean age
at diagnosis was 71 years (range 18–99 years). Most patients were
diagnosed in stage IV (35%). The proportion of patients from non-
Western origin did not change over time (data not shown). Table 2
Table 1 Distribution of origin of non-Western patients with stomach
cancer
Country of birth Number of patients
Africa 7
South America 2
Middle East 58
Surinam/Netherlands Antilles and Aruba 18
Far East 26
Russia 6
Total 117
Table 2 Comparison of characteristics of Western immigrants and
autochthonic patients with non-Western patients with stomach cancer in
North East Netherlands
Western
immigrants and
autochthonic
patients
Non-Western
immigrants
% 95% CI % 95% CI P-Value
Gender
Male 66 65–67 62 53–70 0.314
Female 34 33–35 38 30–47
Age
0 – 1 4 ———— o0.001
15–29 0.1 0.1–0.2 4.3 0.6–7.9
30–44 2.5 2.1–2.8 21 13–28
45–59 15 14–16 17 19–35
60–74 40 39–41 35 26–44
75+ 43 42–44 13 7–19
Tumour localisation
Proximal 29 28–30 21 14–29 0.402
Distal 44 43–45 50 41–59
Overlapping lesion 20 19–21 22 15–30
Not otherwise specified 7 7–8 7 2–11
Histological grade
Poor 2.8 2.5–3.2 1.7 0.1–4.1 0.034
Medium 20 19–20 15 9–22
Well 41 40–42 46 37–55
Undifferentiated 0.9 0.7–1.1 3.4 0.1–6.7
Unknown 36 35–37 33 25–42
Stage
a
1 17 16–18 15 8–21 0.125
2 13 13–14 12 6–18
3 16 15–17 20 13–27
4 35 34–36 42 33–51
Unknown 19 18–20 12 6–18
Treatment
Resection 43 42–45 50 41–60 0.207
Resectionþchemotherapy 1.0 0.8–1.3 1.7 0.01–4.1
Chemotherapy 5 4.4–5.3 7 2–11
None/unknown 37 36–38 31 22–39
Other 14 13–15 10 5–16
Abbreviation: CI¼Confidence interval.
aStage 1: T1N0M0, T1N1M0, T2a/bN0M0;
Stage 2: T1N2M0, T2a/bN1M0, T3N0M0; Stage 3: T2a/bN2M0, T3N1M0, T4N0M0,
T3N2M0; Stage 4: T4N1,2,3M0, T1,2,3N3M0, anyTanyNM1.
Table 3 Univariate and multivariate relative 5-year survival analyses for
Western vs non-Western patients with stomach cancer in the Netherlands,
period 1989–2007
Univariate Multivariate
RER
a 95% CI RER
a 95% CI
Country of birth
Western 1 Reference 1 Reference
Non-Western 0.68 0.54–0.87 0.55 0.43–0.70
Age 1.00 0.99–1.00 1.00 0.99–1.00
Gender
Men 1 Reference 1 Reference
Women 0.98 0.92–1.04 0.94 0.88–1.00
Localisation
Proximal 1 Reference 1 Reference
Distal 0.74 0.69–0.80 1.00 0.93–1.08
Overlapping lesion 1.26 1.16–1.37 1.23 1.13–1.34
Not otherwise specified 1.35 1.19–1.53 1.24 1.09–1.41
Histological grade
Well 1 Reference 1 Reference
Medium 1.38 1.12–1.72 1.00 0.81–1.23
Poor 1.93 1.57–2.37 1.21 0.98–1.48
Undifferentiated 1.77 1.23–2.56 1.06 0.73–1.52
Unknown 2.42 1.96–2.98 1.03 0.83–1.27
Stage
b
I 1 Reference 1 Reference
II 2.21 1.95–2.52 2.20 1.94–2.49
III 3.55 3.14–4.00 3.12 2.77–3.51
IV 9.05 8.09–10.11 4.93 4.38–5.54
Therapy
Resection 1 Reference 1 Reference
Resectionþchemotherapy 1.58 1.22–2.03 1.29 0.99–1.67
Chemotherapy 2.3.09 2.73–3.48 1.61 1.40–1.84
None/unknown 6.28 5.84–6.75 3.68 3.37–4.03
Other 4.26 3.90–4.66 2.75 2.48–3.05
Abbreviations: CI¼Confidence interval; RER¼relative excess risk of dying.
aAdjusted for age, gender, localisation, histological grade, stage and treatment.
bStage
1: T1N0M0, T1N1M0, T2a/bN0M0; Stage 2: T1N2M0, T2a/bN1M0, T3N0M0; Stage
3: T2a/bN2M0, T3N1M0, T4N0M0, T3N2M0; Stage 4: T4N1,2,3M0, T1,2,3N3M0,
anyTanyNM1.
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acteristics per group. Non-Western immigrants were diagnosed
on average at a younger age and presented more often with
well-differentiated tumours than Western immigrants or native
patients. No differences were found in localisation, stage or
treatment of the tumours.
Table 3 shows the univariate 5-year relative survival, as well as
the multivariable 5-year relative survival related to age, gender,
histological grade, localisation, stage and treatment. Univariately,
the relative 5-year survival for patients from Western origin was 17
and 31% from non-Western origin. As year of diagnosis did not
change the multivariable model, year of diagnosis was not put into
the final model. In general, risk of dying is slightly decreased in
the multivariable analysis compared with the univariate analysis,
indicating that the risks are influenced by the other confounding
factors in the table. The risk of dying is decreased independently
for patients from non-Western origin: RER 0.55, 95% CI 0.43–0.70.
Furthermore, patients diagnosed with stage II, III or IV show an
increased risk of dying compared with patients with tumours
diagnosed in stage I.
DISCUSSION
Isolated populations are at risk for experiencing access barriers to
the health care system, which can delay diagnosis and worsen
outcome. Although survival rates of stomach cancer have steadily
improved over recent decades, it remains a deadly disease with-
out early diagnosis and treatment, requiring advanced medical
measures (Hartgrink et al, 2009). In the current study, stomach
cancer survival among non-Western immigrants did not suggest
that such barriers existed for them. This observation was contrary
to our expectations, as this group is often considered at risk for
isolation because of factors like a limited social network, religious
convictions, language barriers and a lower socioeconomic status.
(Fontana et al, 1998; Brewster et al, 2000; Nagel et al, 2007; Collins,
Villagran and Sparks, 2008; Butow et al, 2010; Kagawa-Singer et al,
2010). Surprisingly, we observed a better outcome of patients
with stomach cancer from non-Western origin (RER 0.55, 95% CI
0.43–0.70) compared with those of Western origin.
Differences in outcome of stomach cancer can be explained by
differences in patient and tumour characteristics besides the
functioning of the health care system. Although non-Western
immigrants were substantially younger when diagnosed, we did
not observe differences in tumour characteristics, which could
explain this. Patients from non-Western origin, especially first
generation immigrants, however, are more often born in develop-
ing countries where the prevalence of Helicobacter pylori is higher
and acquired at a younger age, than in developed countries.
Although this may explain part of the earlier age of diagnosis, as
H. pylori is considered a class 1 carcinogen, it cannot be the sole
explanation, as some populations in which H. pylori is prevalent
have high incidences of gastric cancer, while other highly infected
populations do not (Singh and Ghoshal, 2006; Yamaoka et al,
2008). Although one would expect young age to be a favourable
factor for survival, multivariate analysis adjusting for age
continued to show a beneficial outcome of first generation
non-Western immigrants.
Perhaps some favourable factors particularly applicable to the
Dutch situation, could have facilitated utilisation of the medical
services notwithstanding different degrees of isolation. We suggest
that the high degree of employment of first generation
non-Western immigrants and the Dutch ‘arbodienst’, a free health
service for employees within every company, could have facilitated
access to medical care despite the language barrier. Further
research is needed, since the observed survival advantage is
unexpected and remains unexplained, especially as there is no
indication that any form of treatment or intervention is applied
more often in this group.
In conclusion, the better survival of first generation non-western
immigrants after stomach cancer compared with the control popula-
t i o nr e m a i n su n e x p l a i n e d ,b u ts u g g e s t st h a ta c c e s st ot h eh e a l t hc a r e
system in Netherlands was not hampered for these immigrants.
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